ArticleTranslational lung cancer research2022

Phase II study of nanoparticle albumin-bound paclitaxel monotherapy for relapsed non-small cell lung cancer with patient-reported outcomes (NLCTG1302).

Satoshi Shoji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.